B. Schaidt

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

R. Petterle, A. Senegaglia, C. Rebelatto, 2021, Stem Cell Research & Therapy.

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

R. Petterle, A. Senegaglia, C. Rebelatto, 2022, Stem cell research & therapy.

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

R. Petterle, A. Senegaglia, C. Rebelatto, 2022, Stem cell research & therapy.

MESENCHYMAL STEM CELLS FOR SCLERODERMA-LIKE GRAFT VERSUS HOST DISEASE: A CASE SERIES

A. Senegaglia, L. Leite, Prs Brofman, 2021 .

Combined Use of Tocilizumab and Mesenchymal Stromal Cells in the Treatment of Severe Covid-19: Case Report

A. Senegaglia, C. Rebelatto, D. Daga, 2021, Cell transplantation.